MEI Pharma Inc./$LITS
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About MEI Pharma Inc.
Lite Strategy Inc is focused on the clinical development of novel therapies for cancer. The company's portfolio of drug candidates includes voruciclib, an oral cyclin-dependent kinase 9 (CDK9) inhibitor and zandelisib, an oral, once-daily, selective PI3K inhibitor. It is a clinical-stage pharmaceutical company committed to the development of novel and differentiated cancer therapies intended to improve outcomes for patients.
Ticker
$LITS
Sector
Primary listing
Employees
4
Headquarters
Website
MEI Pharma Inc. Metrics
BasicAdvanced
$88M
-
-$2.39
0.20
-
Price and volume
Market cap
$88M
Beta
0.2
52-week high
$9.00
52-week low
$1.46
Average daily volume
1.5M
Financial strength
Current ratio
13.504
Quick ratio
13.302
Profitability
EBITDA (TTM)
-17.087
Management effectiveness
Return on assets (TTM)
-36.57%
Return on equity (TTM)
-63.84%
Valuation
Price to book
0.97
Price to tangible book (TTM)
0.97
Price to free cash flow (TTM)
-0.79
Free cash flow yield (TTM)
-126.65%
Free cash flow per share (TTM)
-3.128
Growth
Earnings per share change (TTM)
-189.69%
3-year earnings per share growth (CAGR)
-37.89%
10-year earnings per share growth (CAGR)
-20.32%
MEI Pharma Inc. News
AllArticlesVideos
BTC digital asset field continues to exert its strength, HASHJ launches Bitcoin cloud mining platform with "capital + technology" dual-driven mode
TheNewswire3 months ago
MEI Pharma Announces Closing of $100,000,000 Private Placement to Initiate Litecoin Treasury Strategy, Becoming First and Only Publicly Traded LTC Holder on a National Exchange
Business Wire3 months ago
Why Is MEI Pharma Stock Soaring On Friday?
Benzinga3 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for MEI Pharma Inc. stock?
MEI Pharma Inc. (LITS) has a market cap of $88M as of October 13, 2025.
What is the P/E ratio for MEI Pharma Inc. stock?
The price to earnings (P/E) ratio for MEI Pharma Inc. (LITS) stock is 0 as of October 13, 2025.
Does MEI Pharma Inc. stock pay dividends?
No, MEI Pharma Inc. (LITS) stock does not pay dividends to its shareholders as of October 13, 2025.
When is the next MEI Pharma Inc. dividend payment date?
MEI Pharma Inc. (LITS) stock does not pay dividends to its shareholders.
What is the beta indicator for MEI Pharma Inc.?
MEI Pharma Inc. (LITS) has a beta rating of 0.2. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.